Escalating Payer Pressures Will Crush Margins Despite Fleeting Pipeline Optimism
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 26 Analysts
Published
05 Aug 25
Updated
05 Aug 25
AnalystLowTarget's Fair Value
US$38.00
9.0% overvalued intrinsic discount05 Aug
US$41.41
1Y
-11.7%7D
-3.8%